ClinicalTrials.gg
CompletedNCT06593262Updated Oct 22, 2026

Efficacy of Digital Cognitive Behavioral Therapy for Insomnia (CBT-I)

An interventional study of app-based digital cognitive behavioral therapy for insomnia with AI chatbot and app-based digital cognitive behavioral therapy for insomnia without AI chatbot in Insomnia, sponsored by Chinese University of Hong Kong. Completed at 1 site in Hong Kong. Open to participants aged 18 Years to 25 Years. Per ClinicalTrials.gov, last updated 2026-10-22.

Sponsored by Chinese University of Hong Kong · Not applicable, Interventional, and Supportive care

How we know

Updated Oct 22, 2026Now CompletedStart date moved+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
168
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 25 studies in Sleep Initiation and Maintenance Disorders by Chinese University of Hong Kong — 14 open to participants now, 14 under way, none of them phase 3. Sleep Initiation and Maintenance Disorders · Chinese University of Hong Kong.

Enrollment
7th of 25
168 · median 80
Started
2024
with 2 others
No phase
24 of 25
13 open now
Registered
17th of 25
by date

Among the 25 studies in Sleep Initiation and Maintenance Disorders by Chinese University of Hong Kong, this one is the 7th largest by enrollment, is one of 3 that started in 2024, is one of 24 with no phase, and was the 17th registered.

Sleep Initiation and Maintenance Disorders

2,738 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 735 are open to participants now.

Browse Sleep Initiation and Maintenance Disorders studies →

Open to participants now

14 of the 25 studies in Sleep Initiation and Maintenance Disorders by Chinese University of Hong Kong are open now, in 1 country. Recruiting first, the newest first:

9 more — sign in →

By country, each count listing its studies:

All 14 open studies →

Where they have run

Who these studies take

Of the 394 Sleep Initiation and Maintenance Disorders studies recruiting now, 156 (40%) set no upper age limit and 208 (53%) stop at 75 or younger; 61 take children under 18; 112 take healthy volunteers.

This study: 18 Years to 25 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 25 studies in Sleep Initiation and Maintenance Disorders by Chinese University of Hong Kong, or all of them as a file.
02

Study summary

Insomnia is a common sleep problem, which affects 9.4-38.2% of youths worldwide. Youth insomnia is linked to mental health problems, leading to substantial health and economic burden. The project aims to conduct an assessor-blind, randomized controlled trial to evaluate the efficacy of an app-based CBT-I with AI chatbot in reducing insomnia symptoms among youths, compared to an app-based CBT-I without AI chatbot.

03

Conditions studied

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

i. Youth aged 18 to 25 years (as defined by WHO and evidence on AI mental health chatbots only available for individuals aged 18 years and older)

ii. Online of participation in the study should be provided

iii. Willing to comply with the requirements of the study protocol

iv. The presence of moderate to severe insomnia measured by a score of 15 or above on the Insomnia Severity Index (ISI)

v. difficulties initiating, maintaining or nonrestorative sleep over a 1-month period

vi. Having access to a smartphone and consistent internet access for their smartphone

vii. Accepting the terms of service and privacy policies of the mobile apps used in the study for the delivery of the intervention

Exclusion criteria

Exclusion Criteria:

i. A history of any sleep disorder(s) (other than insomnia disorder) such as narcolepsy, obstructive sleep apnea, and restless legs syndrome

ii. A history of any mental retardation or neuropsychiatric disorder(s) (other than depression and anxiety disorders as they are the secondary outcomes) such as bipolar disorder, schizophrenia, and substance use disorder

iii. Presence of serious suicidality as evidenced by ideation with a plan or an attempt

iv. Receiving any pharmacological treatment (including sleep promoting agents)

v. Receiving any structured psychotherapy

vi. Having shiftwork and trans-meridian travel in the past 3 months and during the intervention

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
168 participants (actual)

Study arms

  • Experimental
    app-based digital cognitive behavioral therapy for insomnia with AI chatbot

    Behavioral: app-based digital cognitive behavioral therapy for insomnia with AI chatbot

  • Active comparator
    app-based digital cognitive behavioral therapy for insomnia without AI chatbot

    Behavioral: app-based digital cognitive behavioral therapy for insomnia without AI chatbot

Interventions

  • Behavioralapp-based digital cognitive behavioral therapy for insomnia with AI chatbot

    digital cognitive behavioral therapy for insomnia with two-way interactive, intelligent, and patient-centered conversational agents

  • Behavioralapp-based digital cognitive behavioral therapy for insomnia without AI chatbot

    digital cognitive behavioral therapy for insomnia without two-way interactive, intelligent, and patient-centered conversational agents

06

What researchers measure

Primary outcomes

  1. Insomnia Severity Index

    the severity of insomnia symptoms

    Time frame: a) baseline; b) interim during intervention (2-week after baseline); c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline)

Secondary outcomes

  1. sleep onset latency (SOL)

    7-day sleep diary

    Time frame: a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline)

  2. wake after sleep onset (WASO)

    7-day sleep diary

    Time frame: a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline)

  3. sleep efficiency (SE)

    7-day sleep diary

    Time frame: a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline)

  4. Total sleep time (TST)

    7-day sleep diary

    Time frame: a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline)

  5. The Pre-Sleep Arousal Scale

    cognitive and somatic manifestations of arousal near bedtime Total score ranges from 8 to 40. Higher scores suggest increased cognitive and somatic arousal before sleep.

    Time frame: a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline)

  6. The Cognitive Failures Questionnaire

    self-reported failures in perception, memory, and motor function Total score ranges from 0 to 100. Higher scores indicate more self-reported cognitive lapses.

    Time frame: a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline)

  7. Ford Insomnia Response to Stress Test

    personal vulnerability to stress-related insomnia Total score ranges from 9 to 36. Higher scores suggest a greater likelihood of stress-induced insomnia.

    Time frame: a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline)

  8. reduced Horne and Östberg Morningness and Eveningness Questionnaire

    Chronotype preference. Total score ranges from 4 to 25. Higher scores suggest a morning chronotype, while lower scores indicate an evening chronotype.

    Time frame: a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline)

  9. The Dysfunctional Beliefs and Attitudes about Sleep Scale

    Faulty sleep-related beliefs and cognitions, which are cognitive aspects typically involved in the maintenance of insomnia. Total score range of 0 to 160, with higher scores indicating stronger dysfunctional beliefs about sleep.

    Time frame: a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline)

  10. Patient Health Questionnaire-9

    The severity of depressive symptoms. Total score range of 0 to 27, where higher scores signify higher levels of depressive symptoms.

    Time frame: a) baseline; b) interim during intervention (2-week after baseline); c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline)

  11. General Anxiety Disorder-7

    The severity of anxiety symptoms. Total score range of 0 to 21, with higher scores reflecting higher levels of anxiety symptoms

    Time frame: a) baseline; b) interim during intervention (2-week after baseline); c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline)

  12. The Sleep Hygiene Index

    The practice of sleep hygiene behaviors. Total score ranges from 0 to 52. Higher scores reflect poorer sleep hygiene practices.

    Time frame: a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline)

  13. The Charlotte Attitudes Towards Sleep Scale

    Perception and attitude towards sleep in youths. Total averaged score ranges from 1 to 7. Higher scores denote more positive attitudes about sleep.

    Time frame: a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline)

  14. The Multidimensional Fatigue Inventory

    Five dimensions of fatigue (general fatigue, physical fatigues, mental fatigue, decreased motivation, and decreased activities). Total score ranges from 20 to 100. Higher scores indicate greater fatigue levels.

    Time frame: a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline)

Other outcomes

  1. Treatment Satisfaction Scale

    Treatment Satisfaction Scale includes 8 items with 5-point Likert scale. The total score ranges from 8 to 40. The higher the score means a higher satisfaction.

    Time frame: post-intervention (1-month after baseline)

  2. Treatment Component Adherence

    Treatment Component Adherence Scale. 26 single-item, each item has a scoring between 1 to 5.

    Time frame: post-intervention (1-month after baseline)

  3. Acceptability E-scale questionnaire

    Measures the digital program was acceptable or not. Total scores range from 6 to 30. The higher the score means a more positive evaluation.

    Time frame: post-intervention (1-month after baseline)

  4. The Embodied Conversational Agents Trust Questionnaire

    Measures trust towards the mHealth technologies. Total score ranges from 0 to 15. Higher scores indicate a more positive attitude or greater trust towards the mHealth agent or technology.

    Time frame: post-intervention (1-month after baseline)

07

Study locations

1 site
  • Department of Psychiatry, the Chinese University of Hong Kong
    Hong Kong, Hong Kong
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2024 to primary completion in Jun 2026, 22 months.

Of 1,219 non-industry interventional studies with no phase under Sleep Initiation and Maintenance Disorders, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 35. This study's 22 months is above that.

Counting every sponsor, half of 1,297 studies reached it within 15 months; a quarter within 6 and three quarters within 34.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 22, 2026: primary completion Jul 2026 → Jun 2026 and completion Aug 2026 → Jun 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 18, 2024
First posted
Sep 19, 2024
StartActual
Jul 25, 2024
Primary completionActual
Jun 23, 2026was Jul 2026
CompletionActual
Jun 23, 2026was Aug 2026
Last update
Oct 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Completed
changed Oct 22, 2026
Start date
Jul 26, 2024→Jul 25, 2024
Oct 22, 2026
Primary completion
Jul 2026→Jun 23, 2026 (actual)
Oct 22, 2026
Study completion
Aug 2026→Jun 23, 2026 (actual)
Oct 22, 2026
Show all 1 update
  1. Oct 22, 2026
    Active, not recruiting→Completed
    Start date Jul 26, 2024→Jul 25, 2024
    Primary completion Jul 2026→Jun 23, 2026 (now actual)
    Study completion Aug 2026→Jun 23, 2026 (now actual)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06593262
Responsible party
Tim M. H. Li (Prof., Chinese University of Hong Kong) — Principal investigator
First posted
Sep 19, 2024
Start date
Jul 25, 2024
Primary completion
Jun 23, 2026
Completion
Jun 23, 2026
Last update
Oct 22, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion